Lytix Biopharma AS reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 0.074 million. Revenue was NOK 0.449 million compared to NOK 11.18 million a year ago. Net loss was NOK 31.44 million compared to NOK 0.433 million a year ago.
For the six months, sales was NOK 0.074 million. Revenue was NOK 0.824 million compared to NOK 12.69 million a year ago. Net loss was NOK 51.11 million compared to NOK 15.66 million a year ago.